1. Home
  2. BOLD vs FLNT Comparison

BOLD vs FLNT Comparison

Compare BOLD & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • FLNT
  • Stock Information
  • Founded
  • BOLD 2018
  • FLNT 2010
  • Country
  • BOLD United States
  • FLNT United States
  • Employees
  • BOLD N/A
  • FLNT N/A
  • Industry
  • BOLD
  • FLNT Advertising
  • Sector
  • BOLD
  • FLNT Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • FLNT Nasdaq
  • Market Cap
  • BOLD 49.5M
  • FLNT 58.9M
  • IPO Year
  • BOLD 2024
  • FLNT N/A
  • Fundamental
  • Price
  • BOLD $1.51
  • FLNT $2.18
  • Analyst Decision
  • BOLD Buy
  • FLNT Hold
  • Analyst Count
  • BOLD 3
  • FLNT 1
  • Target Price
  • BOLD $22.50
  • FLNT $3.50
  • AVG Volume (30 Days)
  • BOLD 82.4K
  • FLNT 12.8K
  • Earning Date
  • BOLD 03-27-2025
  • FLNT 04-11-2025
  • Dividend Yield
  • BOLD N/A
  • FLNT N/A
  • EPS Growth
  • BOLD N/A
  • FLNT N/A
  • EPS
  • BOLD N/A
  • FLNT N/A
  • Revenue
  • BOLD N/A
  • FLNT $254,623,000.00
  • Revenue This Year
  • BOLD N/A
  • FLNT $9.20
  • Revenue Next Year
  • BOLD N/A
  • FLNT $8.67
  • P/E Ratio
  • BOLD N/A
  • FLNT N/A
  • Revenue Growth
  • BOLD N/A
  • FLNT N/A
  • 52 Week Low
  • BOLD $1.42
  • FLNT $2.01
  • 52 Week High
  • BOLD $14.72
  • FLNT $4.30
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • FLNT 39.81
  • Support Level
  • BOLD N/A
  • FLNT $2.01
  • Resistance Level
  • BOLD N/A
  • FLNT $2.33
  • Average True Range (ATR)
  • BOLD 0.00
  • FLNT 0.15
  • MACD
  • BOLD 0.00
  • FLNT 0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • FLNT 29.82

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: